<DOC>
	<DOCNO>NCT00534859</DOCNO>
	<brief_summary>The objective feasibility study demonstrate device safe potentially efficacious use patient undergoing high risk Percutaneous Coronary Interventions ( PCI ) .Patients enrol meet inclusion &amp; exclusion criterion .</brief_summary>
	<brief_title>PROTECT I , A Prospective Feasibility Trial Investigating Use IMPELLA RECOVER LP 2.5 System Patients Undergoing High Risk PCI</brief_title>
	<detailed_description />
	<criteria>Signed Informed Consent Non emergent PCI least one de novo restenotic lesion native coronary vessel bypass graft EF &lt; 35 % ST Myocardial Infarction Cardiac Arrest Cardiogenic Shock Thrombus Left Ventricle</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>